Harnal OCAS Prolonged Release Film-coated Tablet 400mcg

INDICATIONS

For the relief of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).

CONTRAINDICATIONS

• Hypersensitivity to tamsulosin hydrochloride, including drug-induced angioedema or any other component of the product.
• A history of orthostatic hypotension.
• Severe hepatic impairment (Child-Pugh scores >9).
• Severe renal impairment with creatinine clearance of less than 10 mL/min.
• Concurrent use of another α1-adrenoceptor inhibitor.

DOSAGE AND ADMINISTRATION

One tablet daily.

The tablet must be swallowed whole and not be broken, crunched or chewed, as this compromises the prolonged release properties of the tablet for the active ingredient. Harnal® OCAS can be taken on an empty stomach, or before, with or after food.